Advertisement

Regressing and Regressed Melanoma

  • Guido Massi
  • Philip E. Leboit

Abstract

Malignant melanoma frequently undergoes extensive, subtotal or even complete regression. Although the regression is a continuous biological and morphological process, we describe the two different histological stages separately, for didactic purposes:
  • regressing melanoma with an “active” inflammatory infiltrate;

  • regressed melanoma in its terminal fibrotic phase.

Keywords

Melanoma Cell Basal Cell Carcinoma Lichen Planus Papillary Dermis Seborrheic Keratosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Avril MF, Charpentier P, Margulis A. Regression of primary melanoma with metastases. Cancer. 1992 Marl5;69(6):1377–1381.PubMedCrossRefGoogle Scholar
  2. Barnhill RL, Mihm MC Jr, Ceballos PI. Angiogenesis and regressing cutaneous malignant melanoma. Lancet. 1992 Apr 18;339(8799):991–992.PubMedCrossRefGoogle Scholar
  3. Bastian BC. Hypothesis: a role for telomere crisis in spontaneous regression of melanoma. Arch Dermatol. 2003 May;139(5):667–668.PubMedCrossRefGoogle Scholar
  4. Clemente CG, Mihm MC Jr, Bufalino R. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996 Apr 1;77(7):1303–1310.PubMedCrossRefGoogle Scholar
  5. Cook MG, Spatz A, Brocker EB, Ruiter DJ. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. J Pathol. 2002 Jun;197(2):188–193.PubMedCrossRefGoogle Scholar
  6. Cook MG. The significance of inflammation and regression in melanoma. Virchows Arch A Pathol Anat Histopathol. 1992;420(2):113–115.PubMedCrossRefGoogle Scholar
  7. Demierre MF. Thin melanomas and regression, thick melanomas and older men. Arch Dermatol. 2002 May;138(5):678–682.PubMedCrossRefGoogle Scholar
  8. Ferry JA. On the mechanism of regression of malignant melanoma. Am J Dermatopathol. 1984 Summer;6 Suppl:287–288.PubMedCrossRefGoogle Scholar
  9. Guitart J, Lowe L, Piepkorn M. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol. 2002 May;138(5):603–608.PubMedCrossRefGoogle Scholar
  10. Harvell JD, Meehan SA, LeBoit PE. Spitz’s nevi with halo reaction: a histopathologic study of 17 cases. J Cutan Pathol. 1997 Nov;24(10):611–619.PubMedCrossRefGoogle Scholar
  11. LeBoit PE, Davis-Reed L. Light microscopy: clues to systemic disease in reexcision specimens of basal cell carcinoma. Am J Dermatopathol. 1999 Aug;21(4):361–364.PubMedCrossRefGoogle Scholar
  12. LeBoit PE. Puzzling follicular germinative proliferations. Am J Dermatopathol. 2000 Feb;22(1):87–88.PubMedCrossRefGoogle Scholar
  13. Mc Govern VJ, Shaw HM, Milton GW. Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology 1983;7:673–680.CrossRefGoogle Scholar
  14. Menzies SW, McCarthy WH. Complete regression of primary cutaneous malignant melanoma. Arch Surg. 1997 May;132(5):553–556.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Guido Massi
    • 1
  • Philip E. Leboit
    • 2
  1. 1.Department of PathologyCatholic University Medical SchoolRomeItaly
  2. 2.University of CaliforniaSan FranciscoUSA

Personalised recommendations